Earnings Recaps & Summaries

AU

Autolus Therapeutics plc

AUTL Q1 2026

Shares fell 4.7% after earnings despite an unchanged full-year revenue outlook, reflecting investor concern about slowing growth momentum and cautious incremental progress during the commercial launch phase.

AV

Avax One Technology Ltd

AVX Q1 2026

Avax One’s Q1 results prompted a muted market reaction of +0.6%, reflecting a largely in-line performance as the company's strategic evolution into AI and digital infrastructure progresses without clear near-term inflection in revenue or margin trends.

BE

Beam Global

BEEM Q1 2026

Shares dropped 6.5% after results disappointed investors due to a steep 51% revenue decline driven by order timing issues and a cautious outlook amid geopolitical disruption. Gross margin compression and ongoing net losses despite cost controls also weighed on sentiment.

GA

Engine Gaming and Media, Inc.

GAME Q1 2026

GameSquare’s shares fell 15.2% following earnings as investors reacted negatively to a cautious outlook and a persistent adjusted EBITDA loss, signaling concerns around profitability despite revenue growth and recent acquisitions.

GM

Genmab A/S

GMAB.CO Q1 2026

Genmab’s Q1 2026 results were largely in line with expectations, as reflected by the modest 0.4% stock reaction, with solid revenue growth balanced against ongoing heavy investment and no changes to guidance.

KL

Klarna Group plc

KLAR Q1 2026

Klarna reported solid topline growth and margin expansion in Q1 2026, but the market's neutral reaction reflects tempered investor enthusiasm amid ongoing margin pressures and cautious outlook dynamics.

LF

Lument Finance Trust, Inc.

LFT Q1 2026

Shares fell 7.0% as investors reacted negatively to a cautious outlook and margin pressure amid uneven CRE recovery and increased reserves on legacy assets, signaling limits to near-term growth and profitability.

PA

PAVmed Inc.

PAVM Q1 2026

PAVmed shares fell 3.7% following the earnings release, reflecting investor disappointment with continued delays in key commercial milestones and a cautious near-term outlook despite ongoing pipeline progress.